Lidocaine Ointment
Product Images NDC 51672-3020

2 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lidocaine (NDC 51672-3020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lidocaine 01)

Chemical Structure (Lidocaine 01)
Chemical structure of lidocaine, showing its molecular arrangement with aromatic ring, nitrogen, and alkyl groups. The diagram illustrates the active ingredient lidocaine's chemical composition as labeled.*
FDA Label Image

Principal Display Panel (30 g Tube Carton)

Principal Display Panel (30 g Tube Carton)
Packaging label for Lidocaine Ointment USP, 5%, a topical prescription drug by Sun Pharmaceutical Industries, Inc. The label shows the product name, concentration, dosage form, net weight of 35.44 g (1ΒΌ oz), and usage instructions including child-resistant cap and warnings against eye use. The label includes manufacturer and distributor information for Taro Pharmaceuticals Inc. and Taro Pharmaceuticals U.S.A., Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.